Innate Pharma SA (IPHA)
1.55
+0.07
(+4.73%)
USD |
NASDAQ |
Oct 09, 12:56
Innate Pharma Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 352.30M |
| Cellectis SA | 63.31M |
| Genfit SA | -- |
| Inventiva SA | 733.06M |
Enterprise Value Related Metrics
| Earnings Yield | -38.09% |
| Normalized Earnings Yield | -38.30 |